Anifrolumab (Saphnelo) listed in NS

March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024.

The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is posted.

Lupus Blog Articles:

Living with Lupus: Richelle Johnson’s Story of Strength

Read

Gluten Free Strawberry Rhubarb Crumble Recipe | Lupus Canada

Read

Herbed Tofu Dip – Creamy, Dairy-Free & Protein-Packed

Read